Table Of Contents

1. Market Context & Strategic Relevance

 1.1 Opening Context (Why the market matters)

  1.1.1 Why This Market Is Gaining Strategic Attention

  1.1.2 Business Decisions This Report Supports

 1.2 Scope

 1.3 Research & Methodology

2. Executive Summary

 2.1 Market Snapshot

 2.2 Market Absolute $ Opportunity Assessment & Y-o-Y Analysis, 2022–2035

 2.3 Market Size & Forecast, By Segmentation, 2022–2035

  2.3.1 Market Size By Product

  2.3.2 Market Size By Procedure

  2.3.3 Market Size By End Use

 2.4 Market Share & Bps Analysis By Region, 2025

 2.5 Industry Growth Scenarios – Conservative, Likely & Optimistic

 2.6 Industry CxO's Perspective

3. Market Overview

 3.1 Market Dynamics

  3.1.1 Drivers

  3.1.2 Restraints

  3.1.3 Opportunities

  3.1.4 Key Market Trends

 3.2 Industry PESTLE Analysis

 3.3 Key Industry Forces (Porter's) Impacting Market Growth

 3.4 Industry Supply Chain Analysis

  3.4.1. Component & Subsystem Suppliers

  3.4.2. Structural Heart Device Manufacturers

  3.4.3. Distributors & Channel Partners

  3.4.4. End Users (Hospitals, ASCs, Cardiac Catheterization Labs)

 3.5 Industry Life Cycle Assessment

4. Statistical Insights & Trends Reporting

4.1 Procedure Volume & Treatment Utilization Metrics

4.1.1 Structural Heart Intervention Volumes

4.1.2 Procedure Growth & Annual Treatment Trends

4.1.3 Average Procedures per Treating Center

4.1.4 Repeat Intervention & Reintervention Rates

4.2 Device Performance & Clinical Outcome Statistics

4.2.1 Procedural Success & Technical Success Rates

4.2.2 Device-Related Complication & Adverse Event Rates

4.2.3 Hospitalization, Recovery & Length-of-Stay Metrics

4.2.4 Device Durability & Follow-Up Outcome Indicators

4.3 Hospital & Physician Adoption Metrics

4.3.1 Structural Heart Centers & Treatment-Center Penetration

4.3.2 Average Procedures per Center & Operator

4.3.3 Transcatheter vs. Surgical Procedure Utilization

4.3.4 Adoption of New-Generation Structural Heart Devices

4.4 Device Economics & Procedure Cost Indicators

4.4.1 Average Device Cost per Procedure

4.4.2 Total Procedure Cost & Hospital Resource Utilization

4.4.3 Device Replacement & Reintervention Economics

4.4.4 Reimbursement & Procedure Coverage Indicators

4.5 Technology, Innovation & Pipeline Activity

4.5.1 Minimally Invasive & Transcatheter Technology Adoption

4.5.2 Next-Generation Device & Delivery-System Development

4.5.3 Clinical Trials & Regulatory Approval Activity

4.5.4 Patent, Product Launch & Technology Innovation Trends

5. Structural Heart Devices Market Segmental Analysis & Forecast, By Product, 2022–2035, Value (USD Billion)

 5.1 Introduction

 5.2 Heart valve devices

  5.2.1 Key Trends

  5.2.2 Market Size & Forecast, 2022 – 2035

  5.2.3 Surgical heart valves

  5.2.4 Transcatheter heart valves

 5.3 Annuloplasty rings

 5.4 Occluders and delivery systems

 5.5 Other products

6. Structural Heart Devices Market Segmental Analysis & Forecast, By Procedure, 2022–2035, Value (USD Billion)

 6.1 Introduction

 6.2 Replacement procedures

  6.2.1 Key Trends

  6.2.2 Market Size & Forecast, 2022–2035

  6.2.3 SAVR

  6.2.4 TAVR

  6.2.5 TMVR

  6.2.6 Other

 6.3 Repair procedures

  6.3.1 LAAC

  6.3.2 TMVr

  6.3.3 TTVr

  6.3.4 Valvuloplasty

  6.3.5 Other

7. Structural Heart Devices Market Segmental Analysis & Forecast, By End Use, 2022–2035, Value (USD Billion)

 7.1 Introduction

 7.2 Hospitals

  7.2.1 Key Trends

  7.2.2 Market Size & Forecast, 2022–2035

 7.3 Ambulatory surgical centers

 7.4 Cardiac catheterization labs

 7.5 Other end use

8. Structural Heart Devices Market Segmental Analysis & Forecast By Region, 2022–2035, Value (USD Billion)

 8.1 Introduction

 8.2 North America

  8.2.1 Key Trends

  8.2.2 Structural Heart Devices Market Size & Forecast, By Product, 2022–2035

  8.2.3 Structural Heart Devices Market Size & Forecast, By Procedure, 2022–2035

  8.2.4 Structural Heart Devices Market Size & Forecast, By End Use, 2022–2035

  8.2.5 Structural Heart Devices Market Size & Forecast, By Country, 2022–2035

   8.2.5.1 US

   8.2.5.2 Canada

 8.3 Europe

  8.3.1 Key Trends

  8.3.2 Structural Heart Devices Market Size & Forecast, By Product, 2022–2035

  8.3.3 Structural Heart Devices Market Size & Forecast, By Procedure, 2022–2035

  8.3.4 Structural Heart Devices Market Size & Forecast, By End Use, 2022–2035

  8.3.5 Structural Heart Devices Market Size & Forecast, By Country, 2022–2035

   8.3.5.1 Germany

   8.3.5.2 France

   8.3.5.3 UK

   8.3.5.4 Italy

   8.3.5.5 Spain

   8.3.5.6 Poland

   8.3.5.7 Russia

   8.3.5.8 Rest of Europe

 8.4 Asia Pacific

  8.4.1 Key Trends

  8.4.2 Structural Heart Devices Market Size & Forecast, By Product, 2022–2035

  8.4.3 Structural Heart Devices Market Size & Forecast, By Procedure, 2022–2035

  8.4.4 Structural Heart Devices Market Size & Forecast, By End Use, 2022–2035

  8.4.5 Structural Heart Devices Market Size & Forecast, By Country, 2022–2035

   8.4.5.1 China

   8.4.5.2 India

   8.4.5.3 Japan

   8.4.5.4 South Korea

   8.4.5.5 Australia

   8.4.5.6 ASEAN Countries

   8.4.5.7 Rest of Asia Pacific

 8.5 Latin America

  8.5.1 Key Trends

  8.5.2 Structural Heart Devices Market Size & Forecast, By Product, 2022–2035

  8.5.3 Structural Heart Devices Market Size & Forecast, By Procedure, 2022–2035

  8.5.4 Structural Heart Devices Market Size & Forecast, By End Use, 2022–2035

  8.5.5 Structural Heart Devices Market Size & Forecast, By Country, 2022–2035

   8.5.5.1 Brazil

   8.5.5.2 Argentina

   8.5.5.3 Mexico

   8.5.5.4 Colombia

   8.5.5.5 Rest of Latin America

 8.6 Middle East & Africa

  8.6.1 Key Trends

  8.6.2 Structural Heart Devices Market Size & Forecast, By Product, 2022–2035

  8.6.3 Structural Heart Devices Market Size & Forecast, By Procedure, 2022–2035

  8.6.4 Structural Heart Devices Market Size & Forecast, By End Use, 2022–2035

  8.6.5 Structural Heart Devices Market Size & Forecast, By Country, 2022–2035

   8.6.5.1 UAE

   8.6.5.2 Saudi Arabia

   8.6.5.3 Qatar

   8.6.5.4 South Africa

   8.6.5.5 Rest of Middle East & Africa

9. Competitive Landscape

 9.1 Key Players' Positioning

 9.2 Competitive Developments

  9.2.1 Year-Wise Strategies & Development, 2022–2026

 9.3 Market Share Analysis, 2025

 9.4 Product/Service & Application Benchmarking

  9.4.1 Product/Service Specifications & Features By Key Players

  9.4.2 Product/Service Heatmap By Key Players

  9.4.3 Application Heatmap By Key Players

 9.5 Industry Start-Up & Innovation Landscape

 9.6 Key Company Profiles

  9.6.1 Edwards Lifesciences Corporation

   9.6.1.1 Company Overview & Snapshot

   9.6.1.2 Product/Service Portfolio

   9.6.1.3 Key Company Financials

   9.6.1.4 Geographical Presence

   9.6.1.5 SWOT Analysis

  9.6.2 Medtronic plc

  9.6.3 Abbott Laboratories

  9.6.4 Boston Scientific Corporation

  9.6.5 Johnson & Johnson MedTech

  9.6.6 LivaNova PLC

  9.6.7 Artivion, Inc.

  9.6.8 Meril Life Sciences Pvt. Ltd.

  9.6.9 Venus Medtech (Hangzhou) Inc.

  9.6.10 Peijia Medical Limited

  9.6.11 JenaValve Technology, Inc.

  9.6.12 Anteris Technologies Ltd.

  9.6.13 Occlutech Holding AG

  9.6.14 W. L. Gore & Associates, Inc.

  9.6.15 MicroPort CardioFlow Medtech Corporation

  9.6.16 4C Medical Technologies, Inc.

  9.6.17 HighLife SAS

  9.6.18 Cardiovalve Ltd.

  9.6.19 Foldax, Inc.

  9.6.20 CroiValve Ltd.

10. Analyst Recommendations

 10.1 SNS Insider Opportunity Map

 10.2 Industry Low-Hanging Fruit Assessment

 10.3 Market Entry & Growth Strategy

 10.4 Analyst Viewpoint & Suggestions On Market Growth

11. Assumptions

12. Disclaimer

13. Appendix

 13.1 List Of Tables

 13.2 List Of Figures